{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:32:27Z","timestamp":1775032347579,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ovarian cancer ranks fourth in terms of incidence among gynecological malignancies and third as a cause of cancer death in the gynecological field, with oral contraceptives (OCs) exhibiting a potential relationship to ovarian cancer chemoprevention. This meta-analysis aimed to investigate the association between exposure to OCs and the incidence of ovarian cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, PubMed, Web of Science, Embase, and the Cochrane Library were searched for cohort studies on OCs and ovarian cancer incidence, covering the period from the establishment of each database to May 2025. Hazard ratio (HR) and 95% confidence interval (95% CI) were applied to assess the association between OCs and ovarian cancer incidence, with subgroup analyses performed for duration of use, time since OCs discontinuation, and geographical region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This meta-analysis included a total of 11 cohort studies. The results revealed that the OCs exposure group had a significantly lower ovarian cancer incidence than the control group (HR: 0.80, 95% CI: 0.71\u20130.89; P &amp;lt; 0.001; I\n                      <jats:sup>2<\/jats:sup>\n                      = 53.6%). However, no significant difference in incidence was noted between both groups for individuals with an OCs exposure duration of less than 5\u00a0years (HR: 0.98, 95% CI: 0.84\u20131.16; P = 0.857), and a lower incidence was exclusively observed in the OCs exposure group with use lasting more than 5\u00a0years (HR: 0.66, 95% CI: 0.58\u20130.76; P &amp;lt; 0.001). Subgroup analysis revealed that in both European (HR: 0.74, 95% CI: 0.61\u20130.91; P = 0.004) and American (HR: 0.83, 95% CI: 0.68\u20131.01) cohorts, the incidence of ovarian cancer in the exposed group was lower than that in the control group. However, the difference in the latter did not reach statistical significance (P = 0.064), while no difference in ovarian cancer incidence was observed between the two groups in the Asian cohort (HR: 0.93, 95% CI: 0.71\u20131.23; P = 0.628).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrated that OCs exposure can exert a preventive effect on ovarian cancer, but such prevention necessitates a duration of use of more than 5\u00a0years, and the effect is impacted by geographical factors. In the future, OCs may emerge as one of the potential measures for ovarian cancer prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1732719","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:40:43Z","timestamp":1775022043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral contraceptives exposure may reduce the risk of ovarian cancer: a meta-analysis based on cohort studies"],"prefix":"10.3389","volume":"17","author":[{"given":"Qian","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Gynecology, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine","place":["Ningbo, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiani","family":"Ji","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqi","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Yang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/pm.2023.128661","article-title":"Epidemiology and risk factors for ovarian cancer","volume":"22","author":"Ali","year":"2023","journal-title":"Prz. Menopauzalny"},{"key":"B2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.bulcan.2024.05.010","article-title":"The association between oral contraceptive pills and ovarian cancer risk: a systematic review and meta-analysis","volume":"111","author":"Arshadi","year":"2024","journal-title":"Bull. Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/17512433.2018.1536544","article-title":"Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation","volume":"11","author":"Bastianelli","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B4","first-page":"404","article-title":"Oral contraceptive pills. Prevention of ovarian cancer and other benefits","volume":"58","author":"Berchuck","year":"1997","journal-title":"N. C. Med. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.fertnstert.2013.09.015","article-title":"Race\/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race\/ethnic groups of healthy, regularly cycling women","volume":"101","author":"Bleil","year":"2014","journal-title":"Fertil. Steril."},{"key":"B6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/s0140-6736(79)91435-1","article-title":"Incessant ovulation and ovarian cancer","volume":"2","author":"Casagrande","year":"1979","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1469-1809.2006.00257.x","article-title":"Geographical variations in TP53 mutational spectrum in ovarian carcinomas","volume":"70","author":"Dansonka-Mieszkowska","year":"2006","journal-title":"Ann. Hum. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/1471-0528.14601","article-title":"Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review","volume":"124","author":"Darelius","year":"2017","journal-title":"Bjog"},{"key":"B9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5732\/cjc.014.10273","article-title":"Pathobiology of ovarian carcinomas","volume":"34","author":"Devouassoux-Shisheboran","year":"2015","journal-title":"Chin. J. Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"B11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ijgo.70156","article-title":"Environment, lifestyle, and cancer in women","volume":"171","author":"Farina","year":"2025","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0140-6736(71)92335-x","article-title":"Incessant ovulation--a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/ijc.29471","article-title":"Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: results from the EPIC cohort","volume":"137","author":"Fortner","year":"2015","journal-title":"Int. J. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s10552-015-0649-6","article-title":"Reproductive factors, adiposity, breastfeeding and their associations with ovarian cancer in an Asian cohort","volume":"26","author":"Gay","year":"2015","journal-title":"Cancer Causes Control"},{"key":"B15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ijc.29412","article-title":"Contraceptive methods and ovarian cancer risk among Chinese women: a report from the Shanghai Women's health study","volume":"137","author":"Huang","year":"2015","journal-title":"Int. J. Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e007825","DOI":"10.1136\/bmjopen-2015-007825","article-title":"Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study","volume":"5","author":"Hippisley-Cox","year":"2015","journal-title":"BMJ Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"12394","DOI":"10.1038\/s41598-018-30261-8","article-title":"Inflammation is a key contributor to ovarian cancer cell seeding","volume":"8","author":"Jia","year":"2018","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ygyno.2019.03.102","article-title":"The preventable burden of endometrial and ovarian cancers in Australia: a pooled cohort study","volume":"153","author":"Laaksonen","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/qjmed\/hcac187","article-title":"Long-term health outcomes of early menarche in women: an umbrella review","volume":"115","author":"Lee","year":"2022","journal-title":"Qjm"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-025-01660-y","article-title":"Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021","volume":"18","author":"Li","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s11606-018-4425-7","article-title":"Empirical comparison of publication bias tests in meta-analysis","volume":"33","author":"Lin","year":"2018","journal-title":"J. Gen. Intern Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2147\/JIR.S503479","article-title":"Inflammation and immune escape in ovarian cancer: pathways and therapeutic opportunities","volume":"18","author":"Liu","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/s0002-9378(94)05011-8","article-title":"New knowledge in the physiology of hormonal contraceptives","volume":"170","author":"Lobo","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/IJWH.S55210","article-title":"Combining oral contraceptives with a natural nuclear factor-kappa B inhibitor for the treatment of endometriosis-related pain","volume":"6","author":"Maia","year":"2013","journal-title":"Int. J. Womens Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1158\/1055-9965.EPI-16-0011","article-title":"Parity and oral contraceptive use in relation to ovarian cancer risk in older women","volume":"25","author":"McGuire","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1095\/biolreprod.105.042622","article-title":"Carcinogenic potential of ovulatory genotoxicity","volume":"73","author":"Murdoch","year":"2005","journal-title":"Biol. Reprod."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.4049\/jimmunol.0903463","article-title":"Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages","volume":"184","author":"Murphy","year":"2010","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med."},{"key":"B33","first-page":"561","article-title":"Ovarian cancer: an overview","volume":"91","author":"Penny","year":"2020","journal-title":"Radiol. Technol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10552-017-0853-7","article-title":"Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women","volume":"28","author":"Peres","year":"2017","journal-title":"Cancer Causes Control"},{"key":"B35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/ijgc-2019-000983","article-title":"The world ovarian cancer coalition every woman study: identifying challenges and opportunities to improve survival and quality of life","volume":"31","author":"Reid","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1158\/1055-9965.EPI-20-0569","article-title":"Racial\/ethnic differences in ovarian cancer risk: results from the multiethnic cohort study","volume":"29","author":"Sarink","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10552-017-0876-0","article-title":"A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964","volume":"28","author":"Shafrir","year":"2017","journal-title":"Cancer Causes Control"},{"key":"B39","first-page":"19","article-title":"Oral contraceptives: mechanism of action, dosing, safety, and efficacy","volume":"81","author":"Sondheimer","year":"2008","journal-title":"Cutis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian cancer: an integrated review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1007788","DOI":"10.1371\/journal.pgen.1007788","article-title":"Single-cell RNA-sequencing reveals transcriptional dynamics of estrogen-induced dysplasia in the ovarian surface epithelium","volume":"14","author":"Vuong","year":"2018","journal-title":"PLoS Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/j.celrep.2017.02.049","article-title":"Progesterone prevents high-grade serous ovarian cancer by inducing necroptosis of p53-Defective fallopian tube epithelial cells","volume":"18","author":"Wu","year":"2017","journal-title":"Cell Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/JS9.0000000000003398","article-title":"Global, regional, and national burden of ovarian cancer, 1990-2021, and projections to 2050: a cross-sectional analysis of the global burden of disease study 2021","volume":"112","author":"Xie","year":"2026","journal-title":"Int. J. Surg."},{"key":"B44","doi-asserted-by":"publisher","first-page":"04155","DOI":"10.7189\/jogh.14.04155","article-title":"Global burden of gynaecological cancers in 2022 and projections to 2050","volume":"14","author":"Zhu","year":"2024","journal-title":"J. Glob. Health"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1732719\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:40:46Z","timestamp":1775022046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1732719\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":44,"alternative-id":["10.3389\/fphar.2026.1732719"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1732719","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1732719"}}